ArticleProceedings of the National Academy of Sciences of the United States of America2016

VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.

Markus Räsänen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.